IP Library Granted Patent US 11,540,930
Granted Patent B2
US 11,540,930 · App. 15/775,332 · Granted Jan 3, 2023

Implantable endoluminal prosthesis

Inventor: Noureddine Frid (Beersel, BE)
Assignee: INTRESSA VASCULAR S.A.
A61F2/90A61F2002/068A61F2002/823A61F2210/0014A61F2210/0076A61F2230/0069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,540,930
App. No.
15/775,332
Granted
Jan 3, 2023
Kind
B2
Abstract

An implantable endoluminal prosthesis for use in the treatment of aneurysm involving branches is described, where at least one self-expandable braided framework extending along an axis is able to expand from a radially compressed state in a delivery configuration to a radially expanded state. The self-expandable braided framework includes a plurality of layers of wires made of biocompatible material forming a lattice with a plurality of wires of said layers; the wires being integrated in the mesh of at least one of the adjacent layers; the self-expandable braided framework including a lumen in a cylindrical form; characterized in that, in radially expanded state, a ratio of a thickness of a wall of the implantable endoluminal prosthesis in the radially expanded state to the diameter of wire being greater than 3.0; and the surface coverage ratio (SCR) of the braided framework is at least 30% and at most 50%.

Claims (26)

1. An implantable endoluminal prosthesis having an interlocked multilayer configuration, the implantable endoluminal prosthesis consisting essentially of:

a self-expandable braided framework including a plurality of layers of wires made of a biocompatible material, the self-expandable braided framework extending along an axis and able to expand from a radially compressed state in a delivery configuration to a radially expanded state;

wherein:

each layer in the plurality of layers includes a plurality of wires having a given diameter and forming a mesh, wherein plies of the mesh are not distinct at the time of braiding, and a given number of wires of the plies of the first layer being interlocked with the plies of the second layer and/or other layers;

a surface coverage ratio (SCR) of the self-expandable braided framework in the radially expanded state is at least 30% and at most 40%;

a ratio (T 1 /Ø 21 ) of a thickness of a wall of the implantable endoluminal prosthesis, in the radially expanded state, to a diameter of the wire is at least 3.0; and

wires of the interlocked multiple-layer configuration shift to keep a regular distance between adjacent parallel wires, resulting in that the SCR is maintained between a curved state and a straight configuration, each wire in the plurality of wires having a diameter (Ø 21 ) of at least 150 μm.

2. The implantable endoluminal prosthesis according to claim 1 , wherein the ratio (T 1 /Ø 21 ) is at least 4.0.

3. The implantable endoluminal prosthesis according to claim 1 , wherein the self-expandable braided framework includes at least 90 wires and at most 130 wires.

4. The implantable endoluminal prosthesis according to claim 1 wherein the wire diameter (Ø 21 ) of each wire in the plurality of wires is at least 180 μm.

5. The implantable endoluminal prosthesis according to claim 1 wherein the wire diameter (Ø 21 ) of each wire in the plurality of wires is at least 200 μm and at most 220 μm.

6. The implantable endoluminal prosthesis according to claim 1 , wherein the biocompatible material is a metallic substrate selected from the group consisting of: titanium, a nickel-titanium alloy, a stainless steel, and a cobalt-chromium-nickel alloy.

7. The implantable endoluminal prosthesis according to claim 1 , wherein each wire in the plurality of wires has a diameter (Ø 21 ) of more than 150 μm.

8. An implantable endoluminal prosthesis consisting essentially of:

a plurality of wires having a given diameter and forming a self-expandable braided framework capable of being implanted into a lumen of a body vessel, wherein the self-expandable braided framework is delivered into the lumen in a radially compressed state and expands to a radially expanded state,

wherein:

the self-expandable braided framework includes multiple interlocked layers forming, in the radially expanded state, a porous wall, wherein plies of the multiple interlocked layers are not distinct at the time of braiding, and a given number of wires of the plies of the first layer being interlocked with the plies of the second layer and/or other layers;

the self-expandable braided framework, in the radially expanded state, has a surface coverage ratio (SCR) between 30% and 40%;

a diameter (Ø 21 ) of each wire in the plurality of wires is at least 150 μm;

a ratio (T 1 /Ø 21 ) of a thickness of a wall of the implantable endoluminal prosthesis, in the radially expanded state, to a diameter of the wire is at least 3.0; and

the wires of the interlocked multiple-layer configuration shift to keep a regular distance between adjacent parallel wires, resulting in that the SCR is maintained between a curved state and a straight configuration.

9. The implantable endoluminal prosthesis of claim 8 , wherein a thickness of the porous wall is at least four times the diameter of each wire in the plurality of wires.

10. The implantable endoluminal prosthesis of claim 8 , wherein the diameter of each wire in the plurality of wires is at least 200 μm and at most 220 μm.

11. The implantable endoluminal prosthesis of claim 8 , wherein a total number of wires in the self-expandable braided framework is at least 90 wires and less than 130 wires.

12. The implantable endoluminal prosthesis of claim 8 , wherein the wires comprise a biocompatible metallic substrate selected from the group consisting of: stainless steel; nickel-titanium alloys; cobalt-chrome alloys; cobalt-chromium-nickel alloys; alloys of cobalt, nickel, chromium, and molybdenum; cobalt-chromium-vanadium alloys; cobalt-chromium-tungsten alloys; magnesium alloys; titanium alloys; and tantalum alloys.

13. The implantable endoluminal prosthesis according to claim 8 , wherein the diameter (Ø 21 ) of each wire in the plurality of wires is more than 150 μm.

Assignments (3)
CHANGE OF NAME Recorded Oct 18, 2022
From: CARDIATIS S.A.
To: INTRESSA VASCULAR S.A.
Reel/Frame 061703/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2022
From: FRID, NOUREDDINE; CARDIATIS S.A.
To: CARDIATIS S.A.
Reel/Frame 061412/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2018
From: FRID, NOUREDDINE
To: CARDIATIS S.A.
Reel/Frame 046123/0335 →
Priority Claims (1)
IN 3716/DEL/2015 · Nov 13, 2015 · national
Continuity (1)
Related Publication 20180325708A1 · Nov 15, 2018